TipRanks
Go Ultimate55% OFF

Materialise (06MA) AI Stock Analysis

2 Followers
DE:06MA

Materialise

(Frankfurt:06MA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Medical segment growthMedical is the largest quarterly segment at 54% of revenue and is growing near 10%, indicating durable adoption of patient-specific solutions and clinical software. Continued product expansion and clinical workflow development can support recurring demand across hospitals and device customers.
Negative Factors
Software revenue declineSoftware revenue is declining as customers remain cautious and sales cycles lengthen, weakening one of the company’s potentially recurring and scalable revenue streams. Lower software demand can limit operating leverage and make growth more dependent on service and production volumes.

Materialise (06MA) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%50%60%DE:06MA+21.00%EWG+9.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 438.44M
Dividend Yield
―
Average Volume (3M)
530
Price to Earnings (P/E)
29.3
Beta (1Y)
0.91
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
2,556
Sector
Technology
Sector Strength
61
Industry
Software - Application

Materialise Business Overview & Revenue Model

Company Description

Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Eu...

Materialise Earnings Call Summary

Earnings Call Date:Oct 27, 2026(Q3-2026)|% Change Since:-21.43%|Next Earnings Date:Feb 17, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Medical revenue grew nearly 10%, core manufacturing series production increased more than 30%, Phits Dynaprint volumes tripled sequentially, cash generation remained strong, and full-year revenue and Adjusted EBIT guidance was reaffirmed. The main challenges were declining software revenue amid cautious customer spending and extended sales cycles, softer prototyping demand, higher R&D and operating expenses, and a relatively low third-quarter Adjusted EBIT margin.

Positive Updates

Consolidated Revenue Growth
Third-quarter consolidated revenue increased by more than 2% year-over-year to EUR 67.7 million. Excluding the impact of recent divestitures, revenue increased by almost 5%.

Negative Updates

Software Revenue Decline
Software revenue decreased by just over 4% year-over-year in the third quarter to EUR 9.9 million, reflecting continued cautious customer spending and extended sales cycles. For the first nine months, software revenue was EUR 29 million, down 3% year-over-year.

Company Guidance

For full year 2026, Materialise reconfirmed revenue guidance of EUR 273 million to 283 million, fully absorbing the unfavorable revenue impact of the recent RapidFit and Eyewear divestitures, and reaffirmed Adjusted EBIT guidance of EUR 12 million to 14 million, the range raised in August; in the final quarter, it will focus on executing its strategy, maintaining tight cost control and strong cash generation, and continuing to increase investments in its focus areas.

Materialise Risk Analysis

Materialise disclosed 72 risk factors in its most recent earnings report. Materialise reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Changes in our United States federal income tax classification, or that of our subsidiaries, could result in adverse tax consequences to our 10% or greater U.S. shareholders.Q4, 2021
2.As a result of the armed conflict in Ukraine, we have ceased our operations in our office in Kyiv.Q4, 2021
3.Risks Relating to the COVID-19 PandemicQ4, 2021

Materialise Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:06MA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
IMMRIMMR56Neutral$235.76M21.063.45%4.19%4.12%-68.41%
SVCOSVCO48Neutral$207.04M-8.56-28.06%―31.86%33.91%

* Technology Sector Average

Performance Comparison

0%50%100%150%DE:06MAIMMRSVCODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:06MA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:06MAMaterialise NV6.050.8015.24%
IMMRImmersion7.160.609.11%
SVCOSilvaco Group, Inc.5.820.9319.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.